Advanced Biomedical Research
Pentacam topographic changes after collagen cross-linking in patients with keratoconus
Authors
1 Department of Ophthalmology, Isfahan University of Medical Sciences, Isfahan, Iran
2 Nosocomial Infection Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
3 Medical Students' Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
Abstract
Background: Corneal cross-linking (CXL) with riboflavin and ultra-violet A is less invasive in comparison with other procedures such as penetrating keratoplasty. Hence, we planned this study to evaluate the efficacy of CXL in disease progression and to compare keratoconus indices before and 1 year after cross-linking by Pentacam.
Materials and Methods: In this prospective clinical trial, we enrolled 37 eyes of 37 patients suffering from keratoconus who were candidates for CXL. All eyes were examined before and one 1 year after surgery with a slit lamp and Pentacam for corneal topography. To compare the mean of each Pentacam parameter and index before and 1 year after the surgery, we used paired t-test.
Results: There were 23 males and 14 females. The mean age was 21.5 years 18-30 years). At the 12 th month examination, the corneal thickness had decreased (P = 0.0068) and the Index of Height Decentration (IHD) had increased (P = 0.016). There were no statistically significant differences in other indices and parameters 1 year after CXL.
Conclusion: Most of the parameters and indices had not changed during 1 year after CXL. The procedure seems to be effective in stopping the disease progression at least for 12 months after surgery.
Keywords
| 1. |
Caporossi A, Baiocchi S, Mazzotta C, Traversi C, Caporossi T. Parasurgical therapy for keratoconus by riboflavin-ultraviolet type a rays induced cross-linking of corneal collagen: Preliminary refractive results in an Italian study. J Cataract Refract Surg 2006;32:837-45.  |
| 2. |
Hafezi F, Kanellopoulos J, Wiltfang R, Seiler T. Corneal collagen crosslinking with riboflavin/UVA for the treatment of induced keratectasia after LASIK. J Cataract Refract Surg 2007;33:2035-40. |
| 3. |
Waller SG, Steinert RF, Wagoner MD. Long term results of epikeratoplasty for keratoplasty for keratoconus. Cornea 1995;14:84-8. |
| 4. |
Thompson Jr RW, Price MO, Bowers PJ, Price Jr FW. Long-term graft survival after penetrating keratoplasty. Ophthalmology 2003;110:1396-402. |
| 5. |
Ivarsen A, Hjortdal J. Collage cross-linking for advanced progressive keratoconus. Cornea 2013;32:903-6. |
| 6. |
Wollensak G. Crosslinking treatment of progressive keratoconus: New hope. Curr Opin Ophthalmol 2006; 17:357-60. |
| 7. |
Wollensak G, Spoerl E, Seiler T. Riboflavin/ultraviolet-A-induced collagen crosslinking for the treatment of keratoconus. Am J Ophthalmol 2003;135:620-7. |
| 8. |
Koller T, Iseli HP, Hafezi F, Vinciguerra P, Seiler T. Scheimpflug imaging of corneas after collagen cross-linking. Cornea 2009;28:510-5. |
| 9. |
Greenstein SA, Fry KL, Hersh PS. Corneal topography indices after corneal collagen crosslinking for keratoconus and corneal ectasia: One-year results. J Cataract Refract Surg 2011;37:1282-90. |
| 10. |
Feder RS, Gan TJ. Noninflammatory ectatic disorders. In: Krachmer JH, Mannis MJ, Holland EJ, editors. Cornea fundamentals, diagnosis and management. 3 rd ed. Mosby: Elsevier; 2011. p. 865. |
| 11. |
Wollensak G, Spoerl E, Reber F, Seiler T. Keratocyte cytotoxicity of riboflavin/UV-A treatment in vitro. Eye 2004;18:718-22. |
| 12. |
Arbelaez MC, Sekito MB, Vidal C, Choudhury SR. Collagen cross-linking with riboflavin and ultraviolet-A light in keratoconus: One-year results. Oman J Ophthalmol 2009;2:33-8. [PUBMED] 
|
| 13. |
Anastasios JK, Asimellis G. Comparison of Placido disc and Scheimpflug image-derived topography-guided excimer laser surface normalization combined with higher fluence CXL: the Athens Protocol, in progressive keratoconus. Clin Ophthalmol 2013;7:1385-96.
|
)